Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Clinical Studies

Comment on: “Neoadjuvant chemotherapy is noninferior to chemoradiotherapy for early-onset locally advanced rectal cancer in the FOWARC trial”

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Cai J, Lin K, Luo T, Weng J, Liu H, Yuan Z, et al. Neoadjuvant chemotherapy is noninferior to chemoradiotherapy for early-onset locally advanced rectal cancer in the FOWARC trial. Br J Cancer. https://doi.org/10.1038/s41416-024-02652-4.

  2. Jo P, Jung K, Grade M, Conradi LC, Wolff HA, Kitz J, et al. CpG island methylator phenotype infers a poor disease-free survival in locally advanced rectal cancer. Surgery. 2012;151:564–70. https://doi.org/10.1016/j.surg.2011.08.013.

    Article  PubMed  Google Scholar 

  3. Ha YJ, Kim CW, Roh SA, Cho DH, Park JL, Kim SY, et al. Epigenetic regulation of KLHL34 predictive of pathologic response to preoperative chemoradiation therapy in rectal cancer patients. Int J Radiat Oncol Biol Phys. 2015;91:650–8. https://doi.org/10.1016/j.ijrobp.2014.11.013.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

Henan Province Medical Science and Technology Research Project (LHGJ20210992).

Author information

Authors and Affiliations

Authors

Contributions

Letian Qiao wrote the manuscript, Qiumin Yang provided methodological and theoretical support, and Yuan Liu revised the manuscript and provided financial support.

Corresponding author

Correspondence to Yuan Liu.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qiao, L., Liu, Y. & Yang, Q. Comment on: “Neoadjuvant chemotherapy is noninferior to chemoradiotherapy for early-onset locally advanced rectal cancer in the FOWARC trial”. Br J Cancer 130, 1432–1433 (2024). https://doi.org/10.1038/s41416-024-02690-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41416-024-02690-y

Search

Quick links